Table.
Data on Retinal Microcirculation, Blood Pressures, Cardiac Hypertrophy, Microalbuminuria, and Cardiovascular Risk Before and After 6 Months of Hypertension Treatment
| Variable | Baseline | Final |
|---|---|---|
| Clinic SBP (mm Hg) | 157.7±17.2 | 132.4±7.8* |
| Clinic DBP (mm Hg) | 94.5±10.3 | 81.4±6.5* |
| Pulse pressure (mm Hg) | 62.8±14.9 | 50.9±7.1* |
| Weight (kg) | 79.0±13.2 | 79.0±13.5 |
| Body mass index (kg/m2) | 28.9±3.6 | 28.9±3.8 |
| 24‐h SBP (mm Hg) | 136.5±13.4 | 123.5±9.9* |
| 24‐h DBP (mm Hg) | 84.5±9.0 | 75.9±7.3* |
| 24‐h heart rate (bpm) | 73.0±8.0 | 73.5±8.9 |
| Daytime SBP (mm Hg) | 140.8±14.1 | 127.7±10.8* |
| Daytime DBP (mm Hg) | 88.3±9.0 | 79.4±8.1* |
| Nighttime SBP (mm Hg) | 129.6±14.2 | 115.9±10.4* |
| Nighttime DBP (mm Hg) | 77.7±10.4 | 69.8±7.8* |
| LVMI (g/m2) | 113.7±28.5 | 114.2±27.3 |
| LVH1 (%)** | 32 | 28.1 |
| LVH2 (%)† | 46.3 | 42.1 |
| E/A ratio <1 | 23/44 | 22/35 |
| Microalbuminuria (mg/24 h) | 55.6±124.7 | 24.6±29.2 |
| Retinal arteriole diameter (mm) | 0.0842±0.003 | 0.0847±0.003* |
| Retinal venule diameter (mm) | 0.1118±0.001 | 0.1119±0.001 |
| Arteriovenous ratio | 0.7530±0.03 | 0.7563±0.03†† |
| Cardiovascular risk‡ | 13.6±9.5 | 9.8±8.1* |
| Total cholesterol (mg/dL) | 210.7±39.2 | 184.0±32.2* |
| Data are mean ± SD except as indicated. SBP=systolic blood pressure; DBP=diastolic blood pressure; LVH=left ventricular hypertrophy; *p=0.00l; **left ventricular mass index (LVMI) >134 g/m2 for men and >110 g/m2 for women; ††LVMI >111 g/m2 for men and >106 g/m2 for women; ††p<0.005; ‡calculated using the Framingham tables | ||